Literature DB >> 17577389

Off-label and unlicensed prescribing for children: have we made any progress?

D G Waller1.   

Abstract

Entities:  

Mesh:

Year:  2007        PMID: 17577389      PMCID: PMC2000617          DOI: 10.1111/j.1365-2125.2007.02987.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  7 in total

Review 1.  Paediatric prescribing: using unlicensed drugs and medicines outside their licensed indications.

Authors:  J Collier
Journal:  Br J Clin Pharmacol       Date:  1999-07       Impact factor: 4.335

2.  Unlicensed and off label prescribing of drugs in general practice.

Authors:  J McIntyre; S Conroy; A Avery; H Corns; I Choonara
Journal:  Arch Dis Child       Date:  2000-12       Impact factor: 3.791

3.  Unlicensed and off label prescription of drugs to children: population based cohort study.

Authors:  Geert W 'T Jong; Ingo A Eland; Miriam C J M Sturkenboom; John N van den Anker; Bruno H Ch Stricker
Journal:  BMJ       Date:  2002-06-01

4.  The trials and tribulations of doing drug research in children.

Authors:  Doreen Matsui; Charisse Kwan; Erin Steer; Michael J Rieder
Journal:  CMAJ       Date:  2003-11-11       Impact factor: 8.262

5.  Attitudes and experiences of community pharmacists towards paediatric off-label prescribing: a prospective survey.

Authors:  Derek Stewart; Abdul Rouf; Ailsa Snaith; Kathleen Elliott; Peter J Helms; James S McLay
Journal:  Br J Clin Pharmacol       Date:  2007-02-23       Impact factor: 4.335

6.  Survey of unlicensed and off label drug use in paediatric wards in European countries. European Network for Drug Investigation in Children.

Authors:  S Conroy; I Choonara; P Impicciatore; A Mohn; H Arnell; A Rane; C Knoeppel; H Seyberth; C Pandolfini; M P Raffaelli; F Rocchi; M Bonati; G Jong; M de Hoog; J van den Anker
Journal:  BMJ       Date:  2000-01-08

7.  Off label and unlicensed drug use among French office based paediatricians.

Authors:  M Chalumeau; J M Tréluyer; B Salanave; R Assathiany; G Chéron; N Crocheton; C Rougeron; M Mares; G Bréart; G Pons
Journal:  Arch Dis Child       Date:  2000-12       Impact factor: 3.791

  7 in total
  6 in total

Review 1.  Treating disorders of the neonatal central nervous system: pharmacokinetic and pharmacodynamic considerations with a focus on antiepileptics.

Authors:  Maria D Donovan; Geraldine B Boylan; Deirdre M Murray; John F Cryan; Brendan T Griffin
Journal:  Br J Clin Pharmacol       Date:  2015-11-04       Impact factor: 4.335

2.  The science of prescribing.

Authors:  Derek G Waller
Journal:  Br J Clin Pharmacol       Date:  2012-10       Impact factor: 4.335

3.  Pediatric versus adult drug trials for conditions with high pediatric disease burden.

Authors:  Florence T Bourgeois; Srinivas Murthy; Catia Pinto; Karen L Olson; John P A Ioannidis; Kenneth D Mandl
Journal:  Pediatrics       Date:  2012-07-23       Impact factor: 7.124

4.  Comparison of Drug Utilization Patterns in Observational Data: Antiepileptic Drugs in Pediatric Patients.

Authors:  Florence T Bourgeois; Karen L Olson; Annapurna Poduri; Kenneth D Mandl
Journal:  Paediatr Drugs       Date:  2015-10       Impact factor: 3.022

Review 5.  [Off-label use in child and adolescent psychiatry. An ongoing ethical, medical and legal problem].

Authors:  M Kölch; M Allroggen; J M Fegert
Journal:  Nervenarzt       Date:  2009-07       Impact factor: 1.214

6.  The ethics of psychopharmacological research in legal minors.

Authors:  Jacinta Oa Tan; Michael Koelch
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2008-12-08       Impact factor: 3.033

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.